Assessment of liver stiffness measurement-related markers in predicting liver-related events in viral cirrhosis with clinically significant portal hypertension

Figure 4 Subgroup analysis of liver-related events stratified by liver stiffness measurement and its composite indices A: Distribution of liver-related events (LREs) in liver stiffness measurement (LSM) risk groups (≥ 25. 25 kPa vs < 25.25 kPa) in the training and validation cohort; B: Cumulative incidence curve of LREs in LSM risk groups (≥ 25.25 kPa vs < 25.25 kPa) in the training and validation cohort; C: Distribution of LREs in LSM-platelet ratio (LPR) risk groups (≥ 0.35 vs < 0.35) in the training and validation cohort; D: Cumulative incidence curve of LREs in LPR risk groups (≥ 0.35 vs < 0.35) in the training and validation cohort; E: Distribution of LREs in LSM-albumin ratio (LAR) risk groups (≥ 0.57 vs < 0.57) in the training and validation cohort; F: Cumulative incidence curve of LREs in LAR risk groups (≥ 0.57 vs < 0.57) in the training and validation cohort.